Silence Therapeutics plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 25.38 million compared to GBP 17.5 million a year ago. Net loss was GBP 43.27 million compared to GBP 40.49 million a year ago.

Basic loss per share from continuing operations was GBP 0.389 compared to GBP 0.419 a year ago. Diluted loss per share from continuing operations was GBP 0.389 compared to GBP 0.419 a year ago.